This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Antithrombotic Trialists’ Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002; 324:71-86.11786451Antithrombotic Trialists’ Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ2002324718610.1136/bmj.324.7329.71Search in Google Scholar
Tran HA, Anand SS, Hankey GJ, Eikelboom JW. Aspirin resistance. Thromb Res. 2007;120:337-46.10.1016/j.thromres.2006.08.01417241655TranHAAnandSSHankeyGJEikelboomJWAspirin resistanceThromb Res200712033746Open DOISearch in Google Scholar
Pamukcu B. A review of aspirin resistance; definition, possible mechanisms, detection with platelet function tests, and its clinical outcomes. J Thromb Thrombolysis. 2007; 23:213-22.1718639010.1007/s11239-006-9043-2PamukcuBA review of aspirin resistance; definition, possible mechanisms, detection with platelet function tests, and its clinical outcomesJ Thromb Thrombolysis20072321322Search in Google Scholar
Hankey GJ, Eikelboom JW. Aspirin resistance. Lancet. 2006;367:606-17.10.1016/S0140-6736(06)68040-916488805HankeyGJEikelboomJWAspirin resistanceLancet200636760617Open DOISearch in Google Scholar
Sanderson S, Emery J, Baglin T, Kinmonth AL. Narrative review: aspirin resistance and its clinical implications. Ann Intern Med. 2005; 142:370-80.1573845610.7326/0003-4819-142-5-200503010-00012SandersonSEmeryJBaglinTKinmonthALNarrative review: aspirin resistance and its clinical implicationsAnn Intern Med200514237080Search in Google Scholar
Pamukcu B, Oflaz H, Nisanci Y. The role of platelet glycoprotein IIIa polymorphism in the high prevalence of in vitro aspirin resistance in patients with intracoronary stent restenosis. Am Heart J. 2005; 149: 675-80.10.1016/j.ahj.2004.10.00715990752PamukcuBOflazHNisanciYThe role of platelet glycoprotein IIIa polymorphism in the high prevalence of in vitro aspirin resistance in patients with intracoronary stent restenosisAm Heart J200514967580Open DOISearch in Google Scholar
Christiaens L, Macchi L, Herpin D, Coisne D. Duplantier C, Allai J, et al. Resistance to aspirin in vitro at rest and during exercise in patients with angiographically proven coronary artery disease. Thromb Res. 2002; 108:115-9.10.1016/S0049-3848(03)00008-212590946ChristiaensLMacchiLHerpinDCoisneDDuplantierCAllaiJet alResistance to aspirin in vitro at rest and during exercise in patients with angiographically proven coronary artery diseaseThromb Res20021081159Open DOISearch in Google Scholar
Gum PA, Kottke-Marchant K, Welsh PA, White J, Topol EJ. A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease. J Am Coll Cardiol. 2003; 41:961-5.10.1016/S0735-1097(02)03014-012651041GumPAKottke-MarchantKWelshPAWhiteJTopolEJA prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular diseaseJ Am Coll Cardiol2003419615Open DOISearch in Google Scholar
Chen WH, Cheng X, Lee PY, Ng W, Kwok JY, Tse HE et al. Aspirin resistance and adverse clinical events in patients with coronary artery disease. Am J Med. 2007;120:631-5.1760293810.1016/j.amjmed.2006.10.021ChenWHChengXLeePYNgWKwokJYTseHEet alAspirin resistance and adverse clinical events in patients with coronary artery diseaseAm J Med2007120631517602938Search in Google Scholar
Pamukcu B, Oflaz H, Onur I, Oncul A, Ozcan M, Umman B, et al. Clinical relevance of aspirin resistance in patients with stable coronary artery disease: a prospective follow-up study (PROSPECTAR). Blood Coagul Fibrinolysis. 2007; 18:187-92.10.1097/MBC.0b013e328040c11517287637PamukcuBOflazHOnurIOnculAOzcanMUmmanBet alClinical relevance of aspirin resistance in patients with stable coronary artery disease: a prospective follow-up study (PROSPECTAR)Blood Coagul Fibrinolysis2007181879217287637Open DOISearch in Google Scholar
Li JB, Dong HM, Jian Z, Wu XJ, Zhao XH, Yu SY, et al. Responsiveness to aspirin in patients with unstable angina pectoris by whole blood aggregometry. Int J ClinPract. 2009; 63: 407-16.LiJBDongHMJianZWuXJZhaoXHYuSYet alResponsiveness to aspirin in patients with unstable angina pectoris by whole blood aggregometryInt J ClinPract2009634071610.1111/j.1742-1241.2008.01976.xSearch in Google Scholar
Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE Jr, et al. ACC/AHA 2007 Guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: executive summary. J Am Coll Cardiol. 2007; 50:652-726.10.1016/j.jacc.2007.02.028AndersonJLAdamsCDAntmanEMBridgesCRCaliffRMCaseyDEJret alACC/AHA 2007 Guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: executive summaryJ Am Coll Cardiol200750652726Open DOISearch in Google Scholar
Roth GJ, Calverley DC. Aspirin, platelets, and thrombosis: theory and practice. Blood. 1994;83: 885-98.8111062RothGJCalverleyDCAspirin, platelets, and thrombosis: theory and practiceBlood1994838859810.1182/blood.V83.4.885.885Search in Google Scholar
Roth GJ, Majerus PW. The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein. J Clin Invest. 1975; 56: 624-32.10.1172/JCI1081321159076RothGJMajerusPWThe mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction proteinJ Clin Invest19755662432Open DOISearch in Google Scholar
Roth GJ, Stanford N, Majerus PW. Acetylation of prostaglandin synthase by aspirin. Proc Natl Acad Sci USA. 1975;72:3073-6.10.1073/pnas.72.8.3073RothGJStanfordNMajerusPWAcetylation of prostaglandin synthase by aspirinProc Natl Acad Sci USA19757230736Open DOISearch in Google Scholar
Timur AA, Murugesan G, Zhang L, Aung PP, Barnard J, Wang QK, et al. P2RY1 and P2RY12 polymorphisms and on-aspirin platelet reactivity in patients with coronary artery disease. Int J Lab Hematol. 2012; 34: 473-83.2257482410.1111/j.1751-553X.2012.01420.xTimurAAMurugesanGZhangLAungPPBarnardJWangQKet alP2RY1 and P2RY12 polymorphisms and on-aspirin platelet reactivity in patients with coronary artery diseaseInt J Lab Hematol20123447383Search in Google Scholar
Mirkhel A, Pey ster E, Sundeen J, Greene L, Michelson AD, Hasan A, et al. Frequency of aspirin resistance inacommunity hospital. Am J Cardiol. 2006; 98:577-9.1692343910.1016/j.amjcard.2006.03.029MirkhelAPeyster ESundeenJGreeneLMichelsonADHasanAet alFrequency of aspirin resistance inacommunity hospitalAm J Cardiol2006985779Search in Google Scholar
Tantry US, Bliden KP, Gurbel PA. Overestimation of platelet aspirin resistance detection by thrombelasto-graph platelet mapping and validation by conventional aggregometry using arachidonic acid stimulation. J Am Coll Cardiol. 2005;46:1705-9.10.1016/j.jacc.2005.05.09016256872TantryUSBlidenKPGurbelPAOverestimation of platelet aspirin resistance detection by thrombelasto-graph platelet mapping and validation by conventional aggregometry using arachidonic acid stimulationJ Am Coll Cardiol20054617059Open DOISearch in Google Scholar
Cardinal DC, Flower PJ. The electronic aggregometer: a novel device for assessing platelet behavior in blood. J Pharmacol Methods. 1980; 3:135-58.739265410.1016/0160-5402(80)90024-8CardinalDCFlowerPJThe electronic aggregometer: a novel device for assessing platelet behavior in bloodJ Pharmacol Methods1980313558Search in Google Scholar
Mackie IJ, Jones R, Machin SJ. Platelet impedance aggregation in whole blood and its inhibition by antiplatelet drugs. J Clin Pathol. 1984; 37:874-8.620609610.1136/jcp.37.8.874MackieIJJonesRMachinSJPlatelet impedance aggregation in whole blood and its inhibition by antiplatelet drugsJ Clin Pathol19843787484988856206096Search in Google Scholar
Nicholson NS, Panzer-Knodle SG, Haas NF, Taite BB, Szalony JA, Page JD, et al. Assessment of platelet function assays. Am Heart J. 1998; 135:S170-8.10.1016/S0002-8703(98)70245-59588396NicholsonNSPanzer-KnodleSGHaasNFTaiteBBSzalonyJAPageJDet alAssessment of platelet function assaysAm Heart J1998135S1708Open DOISearch in Google Scholar
Sathiropas P, Marbet GA, Sahaphong S, Duckert F. Detection of small inhibitory effects of acetylsalicylic acid (ASA) by platelet impedance aggregometry in whole blood. Thromb Res. 1988; 51:55-62.10.1016/0049-3848(88)90282-4SathiropasPMarbetGASahaphongSDuckertFDetection of small inhibitory effects of acetylsalicylic acid (ASA) by platelet impedance aggregometry in whole bloodThromb Res1988515562Open DOISearch in Google Scholar
Ivandic BT, Giannitsis E, Schlick P, Staritz P, Katus HA, Hohlfeld T. Determination of aspirin responsiveness by use of whole blood platelet aggregometry. Clin Chem. 2007;53:614-9.1733214910.1373/clinchem.2006.081059IvandicBTGiannitsisESchlickPStaritzPKatusHAHohlfeldTDetermination of aspirin responsiveness by use of whole blood platelet aggregometryClin Chem200753614917332149Search in Google Scholar
Lordkipanidze M, Pharand C, Schampaert E, Turgeon J, Palisaitis DA, Diodati JG. A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease. Eur Heart J. 2007; 28:1702-8.1756967810.1093/eurheartj/ehm226LordkipanidzeMPharandCSchampaertETurgeonJPalisaitisDADiodatiJGA comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery diseaseEur Heart J2007281702817569678Search in Google Scholar
Dyszkiewicz-Korpanty AM, Kim A, Burner JD, Frenkel EP, Sarode R. Comparison of a rapid platelet function assay - Verify Now™ Aspirin - with whole blood impedance aggregometry for the detection of aspirin resistance. Thromb Res. 2007; 120:485-8.10.1016/j.thromres.2006.11.006Dyszkiewicz-KorpantyAMKimABurnerJDFrenkelEPSarodeRComparison of a rapid platelet function assay - Verify Now™ Aspirin - with whole blood impedance aggregometry for the detection of aspirin resistanceThromb Res2007120485817229458Open DOISearch in Google Scholar
Mueller MR, Salat A, Stangl P, Murabito M, Pulaki S, Boehm D, et al. Variable platelet response to low-dose ASA and the risk of limb deterioration in patients submitted to peripheral arterial angioplasty. Thromb Haemost. 1997;78:1003-7.9308744MuellerMRSalatAStanglPMurabitoMPulakiSBoehmDet alVariable platelet response to low-dose ASA and the risk of limb deterioration in patients submitted to peripheral arterial angioplastyThromb Haemost1997781003710.1055/s-0038-1657677Search in Google Scholar
Michelson AD, Cattaneo M, Eikelboom JW, Gurbel P, Kottke-Marchant K, Kunicki TJ, et al. Aspirin resistance: position paper of the Working Group on Aspirin Resistance. J Thromb Haemost. 2005; 3: 1309-11.10.1111/j.1538-7836.2005.01351.xMichelsonADCattaneoMEikelboomJWGurbelPKottke-MarchantKKunickiTJet alAspirin resistance: position paper of the Working Group on Aspirin ResistanceJ Thromb Haemost2005313091115892858Open DOISearch in Google Scholar
Eccleston D, Brieger D, Walters D, Rankin J, Mattschoss S, Huynh L, et al. Aspirin resistance predicts an increased risk of in-hospital events in Australian patients with acute coronary syndromes: results from the CARS study. Heart Lung Circ. 2008; 17:S111.10.1016/j.hlc.2008.05.267EcclestonDBriegerDWaltersDRankinJMattschossSHuynhLet alAspirin resistance predicts an increased risk of in-hospital events in Australian patients with acute coronary syndromes: results from the CARS studyHeart Lung Circ200817S111Open DOISearch in Google Scholar
Pamukcu B, Oflaz H, Oncul A, Umman B, Mercanoglu F, Ozcan M, et al. The role of aspirin resistance on outcome in patients with acute coronary syndrome and the effect of clopidogrel therapy in the prevention of major cardiovascular events. J Thromb Thrombolysis. 2006; 22:103-10.10.1007/s11239-006-8952-417008975PamukcuBOflazHOnculAUmmanBMercanogluFOzcanMet alThe role of aspirin resistance on outcome in patients with acute coronary syndrome and the effect of clopidogrel therapy in the prevention of major cardiovascular eventsJ Thromb Thrombolysis2006221031017008975Open DOISearch in Google Scholar
Haffner SM, Lehto S, Ronnemaa T, Py rala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339:229-34.967330110.1056/NEJM199807233390404HaffnerSMLehtoSRonnemaaTPyrala KLaaksoMMortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarctionN Engl J Med1998339229349673301Search in Google Scholar
Fan L, Cao J, Liu L, Li X, Hu G, Hu Y, et al. Frequency, risk factors, prognosis, and genetic polymorphism of the cyclooxygenase-1 gene for aspirin resistance in elderly Chinese patients with cardiovascular disease. Gerontology. 2013; 59:122-31.10.1159/00034248923038044FanLCaoJLiuLLiXHuGHuYet alFrequency, risk factors, prognosis, and genetic polymorphism of the cyclooxygenase-1 gene for aspirin resistance in elderly Chinese patients with cardiovascular diseaseGerontology20135912231Open DOISearch in Google Scholar
Cao J, Liu L, Fan L, Chen T, Hu G, Hu Y, et al. The prevalence, risk factors and prognosis of aspirin resistance in elderly male patients with cardiovascular disease. Aging Male. 2012; 15:140-7.10.3109/13685538.2012.66658422452804CaoJLiuLFanLChenTHuGHuYet alThe prevalence, risk factors and prognosis of aspirin resistance in elderly male patients with cardiovascular diseaseAging Male2012151407Open DOISearch in Google Scholar
Buchanan MR, Schwartz L, Bourassa M, Blister SJ, Peniston CM; BRAT Investigators. Results of the BRAT study—a pilot study investigating the possible significance of ASA nonresponsiveness on the benefits and risks of ASA on thrombosis in patients undergoing coronary artery bypass surgery. Can J Cardiol. 2000; 16:1385-90.11109035BuchananMRSchwartzLBourassaMBlisterSJPenistonCMBRAT Investigators. Results of the BRAT study—a pilot study investigating the possible significance of ASA nonresponsiveness on the benefits and risks of ASA on thrombosis in patients undergoing coronary artery bypass surgeryCan J Cardiol200016138590Search in Google Scholar
Buch AN, Singh S, Roy P, Javaid A, Smith KA, George CE, et al. Measuring aspirin resistance, clopidogrel responsiveness, and postprocedural markers of myonecrosis in patients undergoing percutaneous coronary intervention. Am J Cardiol. 2007;99:1518-22.10.1016/j.amjcard.2007.01.02317531573BuchANSinghSRoyPJavaidASmithKAGeorgeCEet alMeasuring aspirin resistance, clopidogrel responsiveness, and postprocedural markers of myonecrosis in patients undergoing percutaneous coronary interventionAm J Cardiol200799151822Open DOISearch in Google Scholar
Poulsen TS, Kristensen SR, Korsholm L, Haghfelt T, Jorgensen B, Licht PB, et al. Variation and importance of aspirin resistance in patients with known cardiovascular disease. Thromb Res. 2007; 120: 477-84.1718833910.1016/j.thromres.2006.10.022PoulsenTSKristensenSRKorsholmLHaghfeltTJorgensenBLichtPBet alVariation and importance of aspirin resistance in patients with known cardiovascular diseaseThromb Res200712047784Search in Google Scholar
Borna C, Lazarowski E, van Heusden C, Ohlin H, Erlinge D. Resistance to aspirin is increased by ST-elevation myocardial infarction and correlates with adenosine diphosphate levels. Thromb J. 2005; 3:10.10.1186/1477-9560-3-1016045804BornaCLazarowskiEvanHeusden COhlinHErlingeDResistance to aspirin is increased by ST-elevation myocardial infarction and correlates with adenosine diphosphate levelsThromb J2005310Open DOISearch in Google Scholar
Rasmanis G, Vesterqvist O, Green K, Edhag O, Henriksson P. Effects of intermittent treatment with aspirin on thromboxane and prostacyclin formation in patients with acute myocardial infarction. Lancet. 1988;2:245-7.2899236RasmanisGVesterqvistOGreenKEdhagOHenrikssonPEffects of intermittent treatment with aspirin on thromboxane and prostacyclin formation in patients with acute myocardial infarctionLancet19882245710.1016/S0140-6736(88)92537-8Search in Google Scholar
Gachet C, Aleil B. Test antiplatelet therapy. Eur Heart J Suppl. 2008; 10:A28-34.10.1093/eurheartj/sum081GachetCAleilBTest antiplatelet therapyEur Heart J Suppl200810A2834Open DOISearch in Google Scholar
Cattaneo M. Laboratory detection of ‘aspirin resistance’: what test should we use (if any)?. Eur Heart J. 2007; 28:1673-5.1758654010.1093/eurheartj/ehm232CattaneoMLaboratory detection of ‘aspirin resistance’: what test should we use (if any)?Eur Heart J2007281673517586540Search in Google Scholar
Perneby C, Wallen NH, Rooney C, Fitzgerald D, Hjemdahl P. Dose- and time-dependent antiplatelet effects of aspirin. Thromb Haemost. 2006; 95:652-8.16601836PernebyCWallenNHRooneyCFitzgeraldDHjemdahlPDose- and time-dependent antiplatelet effects of aspirinThromb Haemost200695652810.1160/TH05-10-0653Search in Google Scholar
